- Home
- FNGR vs WHWK Comparison
FNGR vs WHWK Comparison
Compare FNGR & WHWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FNGR | WHWK |
|---|---|---|
| Founded | 2016 | 2007 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 96.1M | 95.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | FNGR | WHWK |
|---|---|---|
| Price | $1.41 | $2.66 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | ★ 196.4K | 179.5K |
| Earning Date | 01-13-2026 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $35,881,122.00 | $14,384,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 15.09 | N/A |
| 52 Week Low | $1.10 | $1.39 |
| 52 Week High | $5.20 | $3.81 |
Technical Indicators
Market Signals| Indicator | FNGR | WHWK |
|---|---|---|
| Relative Strength Index (RSI) | 47.25 | 60.70 |
| Support Level | $1.36 | $2.40 |
| Resistance Level | $1.53 | $2.85 |
| Average True Range (ATR) | 0.10 | 0.17 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 13.50 | 69.67 |
Price Performance
Historical ComparisonAbout FNGR FingerMotion Inc.
FingerMotion Inc is engaged in the provision of mobile payment and recharge services in the Chinese market. The company business line includes Telecommunications Products and Services; Value Added Products and Services; Short Message Services (SMS) and Multimedia Messaging Services (MMS); a Rich Communication Services (RCS) platform; Big Data Insights; and a Video Games Division (inactive). It principally earns revenue by providing mobile payment and recharge services to customers of telecommunications companies in China.
About WHWK Whitehawk Therapeutics Inc.
Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.